siRNA therapy reduces triglycerides in patients with uncommon health condition

.ANALYSIS HIGHLIGHT.19 September 2024.

Plozasiran reduced triglyceride amounts through 80% and reduced the threat of pancreatitis in individuals with chronic chylomicronemia, along with or even without a genetic medical diagnosis.

Articles You Can Be Interested In

• Leadership
• Literature
• Spirituality
• Self-Help
• Credit
• Automotive
• Leadership
• Public Policy
• Weather Update
• Weather Update
• Robotics
• Personal Finance
• Green Energy
• Psychology
• Manufacturing
• Travel Guide
• Nutrition
• AI & ML
• Charity
• History